

Please try another search
Sino Biopharmaceutical Limited is an investment holding company principally engaged in the medicine products business. The Company operates through three business segments. The Modernized Chinese Medicine and Chemical Medicine segment is engaged in the manufacture, sale and distribution of modernized Chinese medicine products and western medicine products. The Investment segment is principally engaged in the long term and short term investments. The Other segment is principally engaged in the related medical and hospital business.
Name | Age | Since | Title |
---|---|---|---|
Mingqin Li | 62 | 2015 | VP & Executive Director |
Hsin Tse | 51 | - | VP & Executive Director |
Yi Li | 59 | 2020 | CEO & Executive Director |
Zhoushan Tian | 57 | 2015 | Executive Director |
Cheung Ling Cheng | 57 | 2017 | Executive Vice Chairwoman of the Board |
Ping Tse | 69 | 2016 | Founder & Senior Vice Chairman |
Hong Lu | 52 | 2015 | Independent Non-Executive Director |
Kwok Tung Li | 67 | 2020 | Independent Non-Executive Director |
Y. Y. Tse | 29 | 2015 | Executive Chairman of the Board |
Shanchun Wang | 54 | 2015 | Executive Director |
Lu Fu Zhang | 65 | 2015 | Independent Non-Executive Director |
Dakui Li | 78 | 2004 | Independent Non-Executive Director |
Zhengfei Lu | 59 | 2005 | Independent Non-Executive Director |
Eric S. Y. Tse | 26 | 2019 | Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review